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  1  AHA/ACSM Pre-Participation Questionnaire (AAPQ)3
   –  Recommends a pre-participation physician visit for all 
individuals who have prior cardiovascular conditions, 
symptoms or 2 or more risk factors
  2  AHA Pre-Participation Guidelines for Masters Athletes 
(AHA Masters)4 
   –  Recommends pre-participation ECG for all individuals >40 
y/o who are planning high-level athletic training/competition
   –  Recommends pre-participation stress testing for men (>40 
y/o) and women (>50 y/o) who have 1 risk factor, 









CVD = cardiovascular disease, MI = myocardial infarction
Table 1. Participant Demographics and            
Running Habits
Characteristics
(n=1457)  N %
Age 
     Mean, y (range) 44.5 (35-86)
Gender
     Male 940 64.5
     Female 517 35.5
Risk Factors
     Hypertension 167 11.5
     Hypercholesterolemia 333 22.9
     Diabetes meelitus 27 1.9
     History MI 6 0.4
     History of cardio- vascular dis. 34 2.3
     Family history of CVD 577 39.6
     Ever smoked 578 39.7
Running habits
     Have run marathon/ultramarathon 485 33.3
     Participate in triathlons 230 15.8
  
Table 2. Completion of PPE and Testing Stratified 










visit 316 (51.5) 335 (36.4 <0.001
ECG 299 (48.7) 277 (30.1) <0.001
Stress Test 136 (22.1) 97 (10.5) <0.001
CAC/CIMT 62 (10.1) 27 (3.2) <0.001
  
Table 3. Completion of Pre-participation ECG and 
Stress Testing Stratified by AHA Masters 2001 
Guidelines Screening Results
 Screen IN Screen OUT P-value
ECG 458/1048 (43.7) 105/352 (29.8) <0.001
Stress Test 122/495 (24.6) 111/962 (11.5) <0.001
  
*Values listed as n (%)
AAPQ,AHA/American College of Sports Medicine Pre-participation 
Questionnaire, CAC = coronary artery calcium, CIMT = carotid intima 
media thickness, ECG = electrocardiogram
ECG = electrocardiogram
Figure 1. Screening 
yield of AAPQ for 
recommendation of 
PPE by healthcare 
provider
Figure 2. Screening 
yield of AHA Masters 
2001 Guidelines for 
recommendation of 
PPE stress testing
Figure 3. Forest plot illustrating independent predictors for 
PPE based on AAPQ simulation: Only athlete age was an 
independent predictor of PPE 
Figure 4. Forest plot illustrating independent predictors of stress 
testing based on AHA Masters 2001 Guidelines: Only athlete age 
and plan to complete a marathon/ distance event were independent 
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  –  Given the low risk of running-associated cardiovascular events, it seems unlikely that application of these guidelines are a cost-effective method to screen novice 
runners for further PPE and testing
    •  Further study is required to confirm this concept 
•		Overall,	there	was	low	healthcare	provider	concordance	with	these	guidelines	
  –  PPE was not performed in a substantial percentage of athletes who were “screened in” for further testing 
  –  Conversely, a substantial percentage of athletes who were “screened out” received further evaluation that may have been unnecessary according to the guidelines
•		Athlete	age	was	a	strong	independent	factor	associated	with	PPE	and	testing,
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